Bafna Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on August 14, 2012 to consider the un-audited financial results for the quarter ending June 30, 2012, and the allotment of shares pursuant to conversion of warrants into shares, warrants allotted on March 17, 2011.
Further, the board will fix date, time and venue of 17th annual general meeting of the members of the company and will approve book closure for the purpose of annual general meeting.
The above information is a part of company's filings submitted to BSE.
